Keywords: merck, singulair, shows, promise, asthma, co, leukotriene

Merck's Singulair Shows Promise In Asthma

Article | 30 May 1997

Merck & Co's leukotriene D4 receptor antagonist Singulair (montelukastsodium), may significantly improve chronic symptoms and quality of life for asthmatics, according ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Abbott

Abbott Laboratories

Go to company listing

Related Drugs

Montelukast Sodium

Singulair

Zileutin

Zyflo

Accolate

Go to drug listing